Ronald DeMatteo, MD - Memorial Sloan-Kettering Cancer Center

Ronald DeMatteo, MD, is a member of the Hepatobiliary Service in the Department of Surgery at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of liver, bile duct, and pancreas tumors. Dr. DeMatteo received his medical degree from Cornell Medical College and completed a surgical residency at the University of Pennsylvania. He was a fellow in Surgical Oncology at Memorial Sloan-Kettering Cancer Center before joining the staff. Dr. DeMatteo also performs laboratory research where he investigates how the immune system can be used to fight cancer. 

Marina Symcox, PhD

Marina Symcox, PhD is a cancer survivor and cofounder of the patient support group GIST Support International (www.gistsupport.org). She received her doctorate in biochemistry from the University of Oklahoma, where she also studied mutant protein kinases in her post-graduate research. In 1997, she was diagnosed with advanced terminal Gastrointestinal Stromal Tumor. After spending months in hospice during 2000 and coming close to death, she became one of the first GIST patients to be treated in a clinical trial with the investigational drug “STI-571,” now known as the breakthrough drug Gleevec. Having a remarkable recovery on Gleevec, Marina lives near Tulsa, Oklahoma with her husband and children, and works as a part-time laboratory instructor at the University of Tulsa.

George D. Demetri, MD - Sarcoma Center Dana-Farber Cancer Institute, Boston, Massachusetts

George D. Demetri, MD, works at the Sarcoma Center Dana-Farber Cancer Institute in Boston, MA.